Atlas Trials

A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris

Clinical trial NCT07186413 · RECRUITING

Trial details

NCT number
NCT07186413
Sponsor
Galderma R&D
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2025-09-23
Primary completion
2026-12-31
Enrollment
561

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.